Polynovo Ltd
ASX:PNV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Polynovo Ltd
Other Liabilities
Polynovo Ltd
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Polynovo Ltd
ASX:PNV
|
Other Liabilities
AU$2m
|
CAGR 3-Years
67%
|
CAGR 5-Years
61%
|
CAGR 10-Years
25%
|
|
|
Nanosonics Ltd
ASX:NAN
|
Other Liabilities
AU$19.8m
|
CAGR 3-Years
19%
|
CAGR 5-Years
37%
|
CAGR 10-Years
35%
|
|
|
SDI Ltd
ASX:SDI
|
Other Liabilities
AU$295k
|
CAGR 3-Years
15%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
|
Anteris Technologies Ltd
ASX:AVR
|
Other Liabilities
AU$1.9m
|
CAGR 3-Years
39%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Ansell Ltd
ASX:ANN
|
Other Liabilities
$43.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-3%
|
|
|
L
|
Lumos Diagnostics Holdings Ltd
ASX:LDX
|
Other Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Polynovo Ltd
Glance View
Polynovo Ltd. engages in the provision biodegradable medical devices. The company is headquartered in Melbourne, Victoria and currently employs 122 full-time employees. The Company’s principal activity is the development of medical devices for various applications. The Company’s products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology. BTM is a man-made synthetic polymer that does not contain any biologic materials. BTM is a skin treatment. NovoSorb is a polymer, which is utilizes for the manufacture of novel medical devices, such as Biocompatible polymers. These biocompatible polymers are designed to support different functions of the body and then biodegrade into by-products that can be absorbed and excreted by the body. The company can be produced in a range of formats with different mechanical and degradation properties. In addition to NovoSorb BTM, they can be used for thermoplastic extrusions, filaments for weaving or knitting and as a solution for spray or dip coatings of other devices.
See Also
What is Polynovo Ltd's Other Liabilities?
Other Liabilities
2m
AUD
Based on the financial report for Dec 31, 2025, Polynovo Ltd's Other Liabilities amounts to 2m AUD.
What is Polynovo Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
25%
Over the last year, the Other Liabilities growth was 101%. The average annual Other Liabilities growth rates for Polynovo Ltd have been 67% over the past three years , 61% over the past five years , and 25% over the past ten years .
